There is an ongoing effort to develop in vitro models for the blood-brain barrier (BBB) research and the central nervous system (CNS) drug screening. But the phenotypes of the existing in vitro models are still very remote from those found in vivo. The trouble in establishing in vitro BBB models comes from the unclear mechanism of the BBB formation and maintenance. The astrocytes have been found to be responsible for the maintenance of the BBB, but the studies of the CNS development have shown that the BBB formation starts largely before the gliogenesis.
Introduction
The blood-brain barrier（BBB）forms the anatomical and physiological interface separating the brain from the blood and protecting the microenvironment of the central nervous system（CNS）via controlling the passage of endogenous substances and xenobiotics into and out of the CNS. Meanwhile, it is the most important factor limiting the development of new drugs for the CNS [1] . The majority of patients with CNS disorders could not benefit from the improvement of the CNS pharmaceutical industry because 100% of large-molecule drugs and more than 98% of small-molecule drugs do not cross the BBB [1] . Just as William M. Pardridge said, the BBB is the bottleneck in brain drug development and is the single most important factor limiting the future growth of neurotherapeutics [2] .
The BBB is a multicellular complex consisting of the brain microvascular endothelial cells (BMEC) and the neighboring perivascular cells including astrocytic endfeet, basal lamina, pericytes, microglia and neurons. Because of the distinctive structure of the BBB and the multiple factors in vivo influencing the BBB, in vitro cell-culturebased models have been the main tool to explore the physiology, pathology and pharmacology of the BBB. About 90% of the BBB researches have been based on in vitro BBB models. Thus, in vitro BBB model has been compared to the holy grail of rapid screening of BBB transport by Pardridge [3] . How to establish in vitro models mimicking the characteristics of the BBB has been a hot pot of BBB research area.
An ideal in vitro model of the BBB should be an accurate reproduction of the in vivo barrier both functionally and anatomically. For design and construction of in vitro cell models of the BBB, it is of utmost importance to know how the BBB forms and develops, but the mechanism of the BBB formation and development is still unclear. To establish an ideal in vitro model may be the best way to explore the physiology, pathology and Hypothesis pharmacology of the BBB. Actually, the evolution of the in vitro models of BBB is just a portrayal of the advance in our understanding of the formation and the development of the BBB. Since 1973 when Joo and Karnushina reported the viable microvessels isolated from the brain which could be considered as the first in vitro model of the BBB [4] , a number of in vitro cultured cell models have been developed. The representative in vitro cellculture-based models of the BBB included:
(1) Monocellular model: After the in vitro growth of endothelial cells deriving from the brain capillaries in culture conditions was confirmed [5] , several in vitro models of the BBB using cultured BMEC monolayer from different species have been developed, which include primary cultured or low passage BMEC and immortalized or conditionally immortalized BMEC lines. The BMEC are usually derived from rat, mouse, porcine or bovine. Although the puromycin method has been used to obtain pure cultures of the BMEC and glucocorticoid hormone has been used in BBB models to improve the tightness of the BMECs in BBB models [6] , in vitro models using cultured BMEC monolayer could not mimic in vivo BBB characteristics accurately because of the loss of BBB phenotype including tight junctions, transporters and specific enzymes [4] . The well characterized BMEC lines include RBE4, GP8, bend 3-5, hCMEC/D3 and TY08 [7] [8] . However, the immortalized cell cultures generally fail to form a sufficiently tight barrier for use in permeability studies [9] [10] . After the role of the cerebral microenvironment in maintaining the BBB was recognized, some probable inductive factors such as basic fibroblast growth factor, vascular endothelial growth factor, angiopoietin-1, glial cell line-derived neuropeptides, transforming growth factor-β, cyclic adenosine monophosphate analogues, phosphodiesterase inhibitors, adenylate cyclase activator, glucocorticoid, and so on [11] [12] [13] , have been applied to stimulate the cultured BMEC monolayer to reappear barrier features.
(2) Multicellular model: Since 1981 when Stewart and Wiley provided evidence that the BBB function is not the intrinsic property of the BMECs and the brain microenvironment have a profound influence on the differentiation of the BMECs into BBB phenotype [14] , coculture models have been developed. As the hypothesis that the interactions between BMECs and astrocytes plays an essential role in inducing and maintaining BBB phenotype has been [7] supported by numerous in vitro studies, the BMECastrocyte coculture model is so far the most widely accepted model. The astrocytes could induce the BMECs to present BBB characteristics via contact or non-contact coculture. Even the astrocyte conditioned media could induce the BMES to express BBB phenotype. In addition, the astrocytes could induce the endothelial cells of non-cerebral origins such as umbilical vein, aorta and pulmonary artery to present BBB characteristics. Although astrocyte seems to be the most promising candidate factor stimulating BMEC to present BBB phenotype, pericytes, neurons and some other cells including macrophages, microglia, smooth muscle cells, and so on, have also been applied to establish BBB model via coculture with BMECs [4, 7, 15] . Furthermore, triple coculture models, such as the combination of BMECs, astrocytes and neurons, or the combination of BMECs, pericytes and astrocytes, have been developed [16] . The organotypic brain slices cocultured with BMEC monolayers have also been studied [17] .
(3) Dynamic model: Pulse pressure and shear stress generated by blood flow have been proved to be critical to promoting the differentiation of the BMECs into BBB phenotype [18] . Several flow-based dynamic models have been developed with the co-cultured BMECs and astrocytes exposed in a threedimensional tube system with continuous and pulsatile flow of cultured medium [19] .
In short, there is an ongoing effort to develop in vitro cultured cell models for assessing the in vivo BBB properties [6, 20] . However, the barrier properties of the existing in vitro models are still very remote from those found in vivo. For example, the transendothelial electrical resistance (TEER) of in vivo BBB has been reported to be 1500-2000 Ωcm 2 , but the majority of the existing in vitro models show TEER < 300 Ωcm 2 . The transendothelial permeability coefficient (Pe) of in vivo BBB to sucrose can be as low as < 0.03x10 -6 cm/s, but most in vitro models present Pe > 3x10 -6 cm/s [4, 6, 7, 15, 21] . On the other hand, the correlation between the permeability of in vivo BBB and most in vitro models is still rather low [20, 22] . It could be speculated that the current methods to reconstitute in vitro BBB models may have overlooked one or more key factors in the induction and the maintenance of the BBB.
Hypothesis
The current prominent method to establish in vitro BBB models is based on the hypothesis that the cross-talk between the cells of the neurovascular unit induce the BBB phenotype in the BMECs [21] , but the responsible factors or inductive signals for the formation and development of the BBB are still unclear. Based on the data of the developing CNS, we hypothesize that the neural stem cell is the real initiator of the BBB formation, development and maintenance. This hypothesis includes: (1) the formation of the BBB is initiated by the neural stem cells and various neural progenitors during the earliest stage of CNS angiogenesis; (2) the maintenance of the BBB is driven by the soluble signals produced by the neural stem cells which exist in the dentate gyrus of the hippocampus and the subventricular zone throughout the life; (3) the BMEC-pericyte complex is the anatomical basis of the BBB. The pericytes should be valued equally important as the BMECs for the BBB formation and development.
Discussion
The trouble in establishing in vitro BBB models comes from the unclear mechanism of the BBB formation, maturation and maintenance. Although the astrocyte has been found to induce the differentiation of the BMECs into BBB phenotype and the BMEC-astrocyte coculture is so far the most widely used in vitro BBB model, the role of the astrocyte in the BBB development is still a question. The timing of BBB formation and development is still controversial, but on the basis of previous studies, it is increasingly clear that the BBB forms during embryogenesis largely before the astrocyte generation [23] . The formation of the BBB occurs at 13 th embryonic day (E13) in chick [24] , at E10.5-E17 in mouse and at E17 in rat [25] [26] [27] . BBB-specific influx transporter Glut1 and tight junction molecules occludin, claudin 5 and ZO-1 were each expressed as early as E12 in rodent [23] .
The high TEER is exhibited in the BBB of rats by E21. In human fetuses, P-gp expressed faintly at 8 weeks of gestation (wg) and strongly at 12 wg in BMECs, occludin and claudin-5 expressed at 14 wg, and a barrier to albumin is present at 12 wg [28] . However, during CNS development, astrocytes are first generated directly after birth and extend processes which contact vessels during the first postnatal week. Detailed rat studies have observed complete encirclement of vessels by astrocytes three weeks after birth [23, 29] . Furthermore, it has been proved that astrocyte removal had no effect on the physical barrier of the BBB when using the tracer horseradish peroxidase to investigate integrity. The CNS is vascularized by angiogenesis starting at E4 in chick, at E9-E11 in mouse, and at E11-E12 in rat [23, [25] [26] 30] . It has been confirmed that the BBB formation begins during the earliest stage of the CNS angiogenic development [31] .
While the angiogenesis, the neural tube is undergoing an orderly developmental program [32] . In the mouse or rat cerebral cortex, neurogenesis commences around E12, peaks around E15, and finishes around birth. Oligodendroglia progenitor cells are first observed at E19 and migrate throughout the cortex by birth. The formation of astrocytes and the subsequent ensheathment of vessels by astrocytes start postnatally. Once angiogenic blood vessels invade the CNS, the BMECs and the pericytes begin to form intimate associations with the neural stem cells and various neural precursors in response to the cues provided by the developing CNS [30] . That is, the onset of the BBB formation occurs within a special microenvironment where the BMECs contact with a mixture of neural stem cells (NSCs) and already committed neural precursors. It has been proved that differentiated human neural progenitor cells can also induce BBB properties in rodent BMECs [33] . So the BBB formation appears to be initiated by signals from neural stem cells and neural progenitor cells.
The nervous system evolves prior to the vascular system. The development of the vascular system may be driven by the guidance cues originated first in the CNS. So does the BBB. It has been supported by the confirmation of the roles of vascular endothelial growth factor and Wnt/beta-catenin signaling pathway, which could be secreted consistently by the neurons from embryo to adulthood, in inducing and regulating CNS angiogenesis and BBB formation [31, 34] .
The stem cell niche is a specialized microenvironment found in specific regions of the adult mammalian brain (subventricular zone, SVZ, and subgranular zone in the hippocampus, SGZ) where NSCs persist throughout life [35] . In the SVZ stem cell niche, the BMECs directly interact with the neural stem cells, lacking astrocyte endfeet and pericyte coverage [35] . This direct contact between the BMECs and the neural stem cells and precursors exist lifelong. It implies that the signals generated by the neural stem cells and precursors could freely reach the remote BMECs of the CNS. Neurogenesis occurs throughout adulthood in mammals, and it has been suggested that the neural stem cells and progenitors may reside throughout the CNS. So we speculate that the BBB maintenance after birth is still driven by the signals generated by the neural stem cells in the niche in the SVZ and the SGZ.
Recent studies have proved the crucial involvement of pericytes in CNS angiogenesis and BBB formation [31, 36] . During the development, they are present in the earliest stages of CNS angiogenesis and BBB formation. The pericytes appear to be involved in capillary sprouting regulation, vessel guidance, and basement membrane formation [31, 37] . They have been found more effective than astrocytes in the induction of BMECs to present paracellular tightness in rat. Thus, as the nearest neighbors of the BMECs during BBB development, the pericytes should not be simply regarded as one of the inducers of the BBB formation any longer. They are one of the most fundamental roles of the cellular architecture of the BBB. The pericytes and the BMECs constitute the BMEC-pericyte complex that is the anatomical basis of the BBB.
To understand the mechanism of the BBB formation and maintenance is the precondition of establishing an in vitro cell-cultured BBB model to simulate in vivo condition as closely as possible. Based on our hypothesis we suggest using the NSCs to induce the BMEC-pericyte complex to establish in vitro BBB models (Fig.2) . The further research on the role of the neural stem cells in the BBB formation and maintenance may elucidate the mechanism of the BBB development.
